141 related articles for article (PubMed ID: 10974400)
1. Thymosin alpha(1) application augments immune response and down-regulates tumor weight and organ colonization in BALB/c-mice.
Beuth J; Schierholz JM; Mayer G
Cancer Lett; 2000 Oct; 159(1):9-13. PubMed ID: 10974400
[TBL] [Abstract][Full Text] [Related]
2. Thymic humoral factor-gamma 2 augments immune cell response and exerts antitumor activity in murine model systems.
Beuth J; Schierholz JM; Mayer G; Keisari Y
Anticancer Res; 2000; 20(6B):4473-6. PubMed ID: 11205290
[TBL] [Abstract][Full Text] [Related]
3. Application of standardized mistletoe extracts augment immune response and down regulates metastatic organ colonization in murine models.
Braun JM; Ko HL; Schierholz JM; Weir D; Blackwell CC; Beuth J
Cancer Lett; 2001 Sep; 170(1):25-31. PubMed ID: 11448531
[TBL] [Abstract][Full Text] [Related]
4. Application-dependent immunomodulating and antimetastatic efficacy of thymic peptides in BALB/c-mice.
Beuth J; Schierholz JM; Ko HL; Braun JM
In Vivo; 2001; 15(5):403-6. PubMed ID: 11695237
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulating and antimetastatic activity of thymic peptides in BALB/c mice.
Beuth J; Schierholz JM; Mayer G
Anticancer Res; 1999; 19(4B):2993-5. PubMed ID: 10652583
[TBL] [Abstract][Full Text] [Related]
6. Standardized mistletoe extract augments immune response and down-regulates local and metastatic tumor growth in murine models.
Braun JM; Ko HL; Schierholz JM; Beuth J
Anticancer Res; 2002; 22(6C):4187-90. PubMed ID: 12553054
[TBL] [Abstract][Full Text] [Related]
7. Intraperitoneal co-administration of thymosin alpha-1 ameliorates streptozotocin-induced pancreatic lesions and diabetes in C57BL/6 mice.
Qiu L; Zhang C; Zhang J; Liang J; Liu J; Ji C; Yang JY
Int J Mol Med; 2009 May; 23(5):597-602. PubMed ID: 19360317
[TBL] [Abstract][Full Text] [Related]
8. Thymosin α-1 in cancer therapy: Immunoregulation and potential applications.
Wei Y; Zhang Y; Li P; Yan C; Wang L
Int Immunopharmacol; 2023 Apr; 117():109744. PubMed ID: 36812669
[TBL] [Abstract][Full Text] [Related]
9. Immunopotentiation in mice bearing a spontaneous transplantable T-cell lymphoma: role of thymic extract.
Shanker A; Singh SM
Neoplasma; 2003; 50(4):272-9. PubMed ID: 12937840
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of immune responses to neem leaf extract (Azadirachta indica) correlates with antineoplastic activity in BALB/c-mice.
Beuth J; Schneider H; Ko HL
In Vivo; 2006; 20(2):247-51. PubMed ID: 16634526
[TBL] [Abstract][Full Text] [Related]
11. Thymalfasin: an immune system enhancer for the treatment of liver disease.
Sjogren MH
J Gastroenterol Hepatol; 2004 Dec; 19(12):S69-72. PubMed ID: 15641207
[TBL] [Abstract][Full Text] [Related]
12. Influence of treatment with the immunomodulatory effective dose of the beta-galactoside-specific lectin from mistletoe on tumor colonization in BALB/c-mice for two experimental model systems.
Beuth J; Ko HL; Gabius HJ; Pulverer G
In Vivo; 1991; 5(1):29-32. PubMed ID: 1932621
[TBL] [Abstract][Full Text] [Related]
13. Thymosin alpha1 accelerates restoration of T cell-mediated neutralizing antibody response in immunocompromised hosts.
Li CL; Zhang T; Saibara T; Nemoto Y; Ono M; Akisawa N; Iwasaki S; Maeda T; Onishi S
Int Immunopharmacol; 2002 Jan; 2(1):39-46. PubMed ID: 11789668
[TBL] [Abstract][Full Text] [Related]
14. Effect of thymosin alpha 1 on the antitumor activity of tumor-associated macrophage-derived dendritic cells.
Shrivastava P; Singh SM; Singh N
J Biomed Sci; 2004; 11(5):623-30. PubMed ID: 15316138
[TBL] [Abstract][Full Text] [Related]
15. Thymic factor-induced reduction of pulmonary metastases in mice with FSA-1 fibrosarcoma.
Tomazic VJ; Sacasa CR; Loftus A; Suter CS; Elias GE
Clin Exp Metastasis; 1988; 6(1):17-25. PubMed ID: 2961496
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of thymosin α 1 in nonclinical models of the immune-suppressing indications melanoma and sepsis.
King RS; Tuthill C
Expert Opin Biol Ther; 2015; 15 Suppl 1():S41-9. PubMed ID: 25643200
[TBL] [Abstract][Full Text] [Related]
17. [Characteristics in antitumor effects of organic silicon related compounds].
Fukushima K
Gan To Kagaku Ryoho; 1989 Jun; 16(6):2173-81. PubMed ID: 2544147
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy with natural interleukins and/or thymosin alpha 1 potently augments T-lymphocyte responses of hydrocortisone-treated aged mice.
Hadden JW; Saha A; Sosa M; Hadden EM
Int J Immunopharmacol; 1995 Oct; 17(10):821-8. PubMed ID: 8707447
[TBL] [Abstract][Full Text] [Related]
19. Thymosin alpha 1 in the treatment of cancer: from basic research to clinical application.
Garaci E; Pica F; Rasi G; Favalli C
Int J Immunopharmacol; 2000 Dec; 22(12):1067-76. PubMed ID: 11137613
[TBL] [Abstract][Full Text] [Related]
20. Protective activity of thymosin alpha 1 against tumor progression in immunosuppressed mice.
Ishitsuka H; Umeda Y; Sakamoto A; Yagi Y
Adv Exp Med Biol; 1983; 166():89-100. PubMed ID: 6650286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
